Skip to content
Politically.com Search all
Menu

HR 1262 119th Congress

Mikaela Naylon Give Kids a Chance Act

To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.

Official Title as Introduced Congress.gov

Introduced Feb 12, 2025 Latest action Dec 2, 2025 Sponsor: Rep. McCaul, Michael T. [R-TX-10] Health
Open official Congress.gov record
Source: Congress.govUpdated 2026-09-13 20:07:03 UTC.

Source-linked procedural record

Bill journey

19 dated records

This is a chronology, not a progress score. Politically.com does not classify stages or infer what comes next. Records sharing a date are grouped because not every source field supplies a time.

Congress.gov Recently refreshed U.S. Senate XML Recently refreshed
Introduction 1 One supplied introduction date.
Official actions 15 15 dated action records.
Committees 1 1 undated relationship.
Amendments 0 No record is cached.
Text versions 3 3 dated, 0 without a supplied date.
House roll calls 0 No exact legislation-key match in the House-vote cache.
Senate roll calls 0 No exact document-key match in the Senate-vote cache.
Related measures 10 10 undated relationships.
Linked law 0 No linked law record is cached; this does not predict outcome.
  1. Official action Congress.gov

    Referred to the House Committee on Energy and Commerce.

    IntroReferral · House floor actions · Code H11100

    Open bill record

    Official action Congress.gov

    Introduced in House

    IntroReferral · Library of Congress · Code Intro-H

    Open bill record

    Official action Congress.gov

    Introduced in House

    IntroReferral · Library of Congress · Code 1000

    Open bill record

    Text version Congress.gov

    Introduced in House

    A dated text-version record is available.

    Open text record
  2. Official action Congress.gov

    Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 47 - 0.

    Committee · House committee actions · Code H19000

    Open bill record

    Official action Congress.gov

    Committee Consideration and Mark-up Session Held

    Committee · House committee actions · Code H15001

    Open bill record
  3. Official action Congress.gov

    Placed on the Union Calendar, Calendar No. 304.

    Calendars · House floor actions · Code H12410

    Open bill record

    Official action Congress.gov

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-352.

    Committee · House floor actions · Code H12200

    Open bill record

    Official action Congress.gov

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-352.

    Committee · Library of Congress · Code 5000

    Open bill record

    Text version Congress.gov

    Reported in House

    A dated text-version record is available.

    Open text record
  4. Text version Congress.gov

    Engrossed in House

    A dated text-version record is available.

    Open text record

    Official action Congress.gov · 4:01 pm UTC

    Mr. Carter (GA) moved to suspend the rules and pass the bill, as amended.

    Floor · House floor actions · Code H30300

    Open bill record

    Official action Congress.gov · 4:01 pm UTC

    Considered under suspension of the rules. (consideration: CR H4929-4935)

    Floor · House floor actions · Code H30000

    Open bill record

    Official action Congress.gov · 4:01 pm UTC

    DEBATE - The House proceeded with forty minutes of debate on H.R. 1262.

    Floor · House floor actions · Code H8D000

    Open bill record

    Official action Congress.gov · 4:27 pm UTC

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4929-4932)

    Floor · House floor actions · Code H37300

    Open bill record

    Official action Congress.gov · 4:27 pm UTC

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4929-4932)

    Floor · Library of Congress · Code 8000

    Open bill record

    Official action Congress.gov · 4:27 pm UTC

    Motion to reconsider laid on the table Agreed to without objection.

    Floor · House floor actions · Code H38310

    Open bill record
View the complete bill journey as an accessible table
Every dated cached record linked to HR 1262. Same-date row order does not assert procedural sequence.
Date and timeRecordOfficial detailSource
IntroductionIntroduced Introduced in the House. Congress.gov
Official actionReferred to the House Committee on Energy and Commerce. No additional detail supplied.IntroReferral · House floor actions · Code H11100 Congress.gov
Official actionIntroduced in House No additional detail supplied.IntroReferral · Library of Congress · Code Intro-H Congress.gov
Official actionIntroduced in House No additional detail supplied.IntroReferral · Library of Congress · Code 1000 Congress.gov
Text versionIntroduced in House A dated text-version record is available. Congress.gov
Official actionOrdered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 47 - 0. No additional detail supplied.Committee · House committee actions · Code H19000 Congress.gov
Official actionCommittee Consideration and Mark-up Session Held No additional detail supplied.Committee · House committee actions · Code H15001 Congress.gov
Official actionPlaced on the Union Calendar, Calendar No. 304. No additional detail supplied.Calendars · House floor actions · Code H12410 Congress.gov
Official actionReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-352. No additional detail supplied.Committee · House floor actions · Code H12200 Congress.gov
Official actionReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-352. No additional detail supplied.Committee · Library of Congress · Code 5000 Congress.gov
Text versionReported in House A dated text-version record is available. Congress.gov
Text versionEngrossed in House A dated text-version record is available. Congress.gov
Official actionMr. Carter (GA) moved to suspend the rules and pass the bill, as amended. No additional detail supplied.Floor · House floor actions · Code H30300 Congress.gov
Official actionConsidered under suspension of the rules. (consideration: CR H4929-4935) No additional detail supplied.Floor · House floor actions · Code H30000 Congress.gov
Official actionDEBATE - The House proceeded with forty minutes of debate on H.R. 1262. No additional detail supplied.Floor · House floor actions · Code H8D000 Congress.gov
Official actionOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4929-4932) No additional detail supplied.Floor · House floor actions · Code H37300 Congress.gov
Official actionPassed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4929-4932) No additional detail supplied.Floor · Library of Congress · Code 8000 Congress.gov
Official actionMotion to reconsider laid on the table Agreed to without objection. No additional detail supplied.Floor · House floor actions · Code H38310 Congress.gov
Official actionReceived in the Senate. No additional detail supplied.IntroReferral · Senate Congress.gov

House roll calls join only on matching Congress, legislation type, and number. Senate roll calls join only on matching source-supplied document type and number, not question text. Committee and related-measure relationships have no date in their relationship records and therefore are counted above but never placed on the chronology.

Congressional Research Service

CRS summary

Introduced in House Feb 12, 2025

Give Kids a Chance Act of 2025This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the billmodifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met;permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement;renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; andreauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra, a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Official documents

Text versions